Marco Meglio

Articles

First patient treated in adolescent epilepsy trial assessing NeuroPace RNS system

May 17, 2022

Since its approval for the treatment of medical refractory epilepsy in 2013, the closed-loop neuromodulation device has had its efficacy and safety confirmed in several pivotal studies and will now be assessed in focal epilepsy in the RESPONSE trial.